Dear BIOSTEMI Investigators and Study Teams,
We are pleased to introduce you to the first issue of the BIOSTEMI Study Newsletter.
We would like to inform you that we have recently started enrolment of patients in the BIOSTEMI study. The first patient was randomized on 27 April 2016 at Bern Inselspital. To date, a total of 7 study sites have been initiated. 2 study sites have started the screening process and we have already randomized a total of 138 subjects.
We encourage all initiated study sites to start screening and we are looking forward to seeing the first patients randomized at these sites!
At the moment, 7 study centers have been initiated and 5 study sites are currently actively enrolling patients in the BIOSTEMI study. Please see here below the current list of investigators and initiated study sites.
Initiation visits have been recently performed for the following study sites:
Additional initiation visits have been scheduled shortly for the following study site:
At the moment, a total of 138 patients have been enrolled in the BIOSTEMI trial. 26 additional patients have been randomized during the last month. Please see here below the latest enrolment chart.
ENROLMENT CHART (updated 31.08.2016)
ENROLMENT CHART ACCORDING TO STUDY SITE ENROLMENT CHART (updated 31.08.2016)
Study sites, investigators and study teams previously involved in the BIOSCIENCE trial should be able to use their old username and password to have access to CARDIOBASE and randomize patients for the BIOSTEMI study. If needed, the password can be reset by contacting Lena Maurer at email@example.com.
We would like to thank you all very much for your efforts and commitment to the BIOSTEMI study. Please do not hesitate to contact us in case of questions or concerns related to the study.